New vaccine technologies are not being ignored, but take longer to develop, which is why traditional platforms were prioritized, said Janet Woodcock, acting US Food and Drug Administration commissioner.
Sen. Lisa Murkowski, R-Alaska, did not give specifics, but indicated during a 4 November Senate Health, Education, Labor and Pensions...